FDA: Pelvic Mesh Used To Treat Prolapse Can Erode Vagina In 11-18 Percent Of Cases
SILVER SPRING, Md. — The use of surgical mesh to treat pelvic organ prolapse (POP) is less favorable than the use of “native tissue,” the Food and Drug Administration staff says...To view the full article, register now.
Already a subscriber? Click here to view full article